Search for Predictors of Therapeutic Response in Ovarian Carcinoma

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

July 31, 2016

Conditions
Carcinoma of the OvaryFallopian Tube CancerPeritoneal Serous-type Advanced Stage
Interventions
OTHER

blood samples

"blood samples in patients receiving Taxol and carboplatin chemotherapy :~* On Day 1 of the first course of chemotherapy~* On Day 1 of the second course of chemotherapy~* Before the surgery, if programmed via J1 or the fourth cycle of chemotherapy~* At the end of chemotherapy"

OTHER

blood samples

"blood samples in patients receiving Taxol and carboplatin chemotherapy with avastin:~* On Day 1 of the first course of chemotherapy~* On Day 1 of the second course of chemotherapy~* Before the surgery, if programmed via J1 or the fourth cycle of chemotherapy~* At the end of chemotherapy"

Trial Locations (7)

14076

Centre François BACLESSE, Caen

49000

Institut de cancerologie de la loire, Angers

59000

Centre Oscar LAMBRET, Lille

75000

Institut CURIE, Paris

35 000

Centre Eugène Marquis, Rennes

44 000

Centre Réné Gauducheau, Nantes

76 000

Centre Henri Becquerel, Rouen

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER

NCT01391351 - Search for Predictors of Therapeutic Response in Ovarian Carcinoma | Biotech Hunter | Biotech Hunter